BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9250158)

  • 21. Increased levels of p21WAF1/Cip1 in human brain tumors.
    Jung JM; Bruner JM; Ruan S; Langford LA; Kyritsis AP; Kobayashi T; Levin VA; Zhang W
    Oncogene; 1995 Nov; 11(10):2021-8. PubMed ID: 7478521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
    Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
    Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
    Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
    O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB
    Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx.
    Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A
    J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.
    Harlozinska A; Bar JK; Montenarh M; Kartarius S
    Oncol Rep; 2002; 9(6):1173-9. PubMed ID: 12375014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
    J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U; Durka S; Weller M
    Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma.
    Hayashi H; Ito T; Yazawa T; Ikeda M; Inayama Y; Nakatani Y; Kameda Y; Nakamura N; Kitamura H
    J Pathol; 2000 Sep; 192(1):26-31. PubMed ID: 10951396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation.
    Doglioni C; Pelosio P; Laurino L; Macri E; Meggiolaro E; Favretti F; Barbareschi M
    J Pathol; 1996 Jul; 179(3):248-53. PubMed ID: 8774478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
    Naka T; Toyota N; Kaneko T; Kaibara N
    Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21WAF1/CIP1 expression in primary lung adenocarcinomas: heterogeneous expression in tumor tissues and correlation with p53 expression and proliferative activities.
    Takeshima Y; Yamasaki M; Nishisaka T; Kitaguchi S; Inai K
    Carcinogenesis; 1998 Oct; 19(10):1755-61. PubMed ID: 9806155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the cell cycle regulators p53, p21(WAF1/CIP1) and p16(INK4a) in human endometrial adenocarcinoma.
    Buchynska LG; Nesina IP
    Exp Oncol; 2006 Jun; 28(2):152-5. PubMed ID: 16837908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.